The Neural Basis of Addiction
Research Group
Goal of our laboratory: is to provide a better understanding of the underlying neurobiology of substance use, with a special emphasis on nicotine and alcohol use. Our work is focused on the role of various brain neurotransmitter systems in driving substance use in clinical populations that are more susceptible to drug use. Work in our laboratory has found that during nicotine withdrawal, females display increased anxiety and a larger dysregulation of stress-associated genes as compared to male subjects. Thus, stress produced by withdrawal is believed to be an important factor that contributes to enhanced vulnerability to nicotine use in females. This finding coincides with human clinical reports indicating that females display higher smoking relapse rates due to intense anxiety produced by nicotine withdrawal. More recent studies have also shown that insulin resistance experienced during diabetic states enhances the rewarding effects of nicotine and intensifies withdrawal states during abstinence. These data suggest that greater rewarding effects of nicotine may contribute to greater susceptibility to nicotine use among patients with diabetes.
Relation to addiction studies: Dr. O’Dell’s laboratory combines neurochemical and molecular approaches with behavioral models to study how various pathways in the brain modulate addictive behavior. The bench work in our laboratory includes in vivo microdialysis paired with mass spectrometry, gene expression analysis using qtPCR, protein level assessment using Western Blot procedures, and changes in drug metabolism using various ELISA methods. The students will also learn behavioral methods that assess the rewarding effects of drugs of abuse such as, self-administration and conditioned place preference methods. At the end of the training program, the student will learn how to integrate behavioral tests with various biochemical research tools in a laboratory that takes an interdisciplinary approach to solving the problems associated with substance misuse. Research questions
Significance of the work: The goal of our laboratory is to provide a better understanding of how various brain neurotransmitter systems play a role in driving drug addiction behavior across various clinical populations. As an example, we have seen that increased anxiety and changes in stress-related genes are increased to a greater extent in female versus male subjects. Thus, stress produced by anxiety is believed to be an important factor contributing to enhanced vulnerability to tobacco abuse in young females. This finding coincides with human clinical reports indicating that females relapse to smoking due to intense anxiety produced by nicotine withdrawal. More recent studies have also shown that diabetic states produce an increase in the rewarding effects of nicotine. These data suggest that greater rewarding effects of nicotine may contribute to greater susceptibility to tobacco abuse among diabetic patients. If you are interested in working in our laboratory, please contact Dr. O'Dell at [email protected] . |